Latest News

General Catalyst is a leading US-based venture capital firm specializing in early-stage and growth investments across various industries, including technology, healthcare, and consumer goods. Known for its strategic approach and deep industry knowledge, General Catalyst not only provides financial support to entrepreneurs but also offers valuable guidance and resources to help them navigate the complex challenges of building and expanding their businesses.

A pioneer in the application of AI in clinical settings, Sheba has played a central role in the development of numerous solutions that are now used across the globe. This includes Aidoc, which was founded at Sheba and now provides advanced AI decision-support tools to many of the world’s leading medical centers.

CAR T-cell therapy is a revolutionary blood cancer treatment that involves extracting and genetically engineering a patient’s T-cells to produce chimeric antigen receptors, or CARs, that facilitate the targeting and elimination of malignant cells.

In a remarkable example of international collaboration, Sheba Medical Center and Peter MacCallum Cancer Centre in Melbourne have embarked on a partnership that showcases the power of innovation, clinical expertise, and shared vision in the fight against one of the world’s most pressing health challenges.

General Catalyst is a leading US-based venture capital firm specializing in early-stage and growth investments across various industries, including technology, healthcare, and consumer goods. Known for its strategic approach and deep industry knowledge, General Catalyst not only provides financial support to entrepreneurs but also offers valuable guidance and resources to help them navigate the complex challenges of building and expanding their businesses.